• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Acusphere Inc

+ Add to Watchlist

ACUS:US

0.6650 USD 0.00000.00%

As of 10:20:08 ET on 08/22/2014.

Snapshot for Acusphere Inc (ACUS)

Open: 0.6650 Day's Range: 0.6650 - 0.6650 Volume: 393
Previous Close: 0.6650 52wk Range: 0.3500 - 1.1100 1-Yr Rtn: +30.39%

Stock Chart for ACUS

No chart data available.
  • ACUS:US 0.6650
  • 1D
  • 1M
  • 1Y
0.6650
Interactive ACUS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ACUS

Current P/E Ratio (ttm) -
Estimated P/E(12/2009) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -12.6000
Est. EPS (USD) (12/2009) -
Est. PEG Ratio -
Market Cap (M USD) 3.29
Shares Outstanding (M) 4.95
30 Day Average Volume 2,202
Price/Book (mrq) -
Price/Sale (ttm) 1.1759
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ACUS

No data available

Company Profile & Key Executives for ACUS

Acusphere, Inc., a specialty pharmaceutical company, develops new drugs and improved formulations for existing drugs. The Company utilizes porous microparticle technology. The company's three initial product candidates are in clinical development. The lead product candidate is a cardiovascular drug in Phase III clinical development for the detection of coronary artery disease.

Martyn D GreenacreChairmanSherri Carroll ObergVice Chairman/Co-Founder
Mark W LeuchtenbergerPresident/CEOWilliam I RamageChief Development Officer
More Company Profile & Key Executives for ACUS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil